|1.||Gibson, C Michael: 18 articles (04/2014 - 01/2002)|
|2.||Murphy, Sabina A: 12 articles (02/2008 - 01/2002)|
|3.||Braunwald, Eugene: 8 articles (04/2014 - 04/2002)|
|4.||TIMI Study Group: 7 articles (02/2008 - 04/2002)|
|5.||Kirtane, Ajay J: 6 articles (02/2009 - 09/2004)|
|6.||Cannon, Christopher P: 6 articles (02/2008 - 04/2002)|
|7.||Giugliano, Robert P: 5 articles (04/2014 - 05/2004)|
|8.||Pride, Yuri B: 4 articles (11/2011 - 02/2008)|
|9.||Morrow, David A: 4 articles (11/2011 - 07/2002)|
|10.||Celik, Turgay: 4 articles (12/2008 - 07/2005)|
07/01/2013 - "The substudy primary endpoint was the incidence of post-PCI TIMI (Thrombolysis In Myocardial Infarction) myocardial perfusion grade 3 (TMPG 3) among patients who received a study drug prior to PCI. "
10/01/2010 - "The objectives of this study were to evaluate the long-term outcome and the prognostic implication of thrombolysis in myocardial infarction myocardial perfusion grade (TMPG) in patients with TC. "
10/01/2008 - "Compared with the control group, the study group showed better Thrombolysis In Myocardial Infarction (TIMI) flow grades and TIMI myocardial perfusion grades (TMPG) immediately after PCI (p = 0.016 and 0.026, respectively). "
01/22/2002 - "Methods and Results- In the LIMIT AMI trial (Limitation of Myocardial Injury following Thrombolysis in Acute Myocardial Infarction) of lytic monotherapy versus lytic plus rhuMAb CD18, early 90-minute TMPG (n=221) and ST segment resolution (n=242) were compared with subsequent SPECT Technetium-99 m Sestamibi, measuring the percentage of the left ventricle with no Sestamibi uptake. "
01/15/2016 - "Quantitative modification of TIMI myocardial perfusion grade (TMPG) by the method of frame counting may improve its sensitivity and the false negative rate for post-reperfusion microvascular dysfunction (MVD) in ST segment-elevated myocardial infarction (STEMI) patients. "
10/01/2006 - "We hypothesized that an abnormal TIMI myocardial perfusion grade (TMPG 0/1/2) and an impaired coronary flow reserve (CFR) as assessed angiographically using the TIMI frame count would be associated with biomarker release, ischemia on Holter monitoring, and adverse clinical outcomes in the PROTECT-TIMI 30 trial of patients with non-ST-elevation ACS undergoing percutaneous coronary intervention (PCI). "
10/01/2006 - "An abnormal TMPG, but not an angiographic CFR, is associated with biomarker status, the occurrence and duration of Holter ischemia, and adverse clinical outcomes among patients with moderate- to high-risk non-ST-elevation ACS undergoing PCI."
10/01/2006 - "The incidence of an ischemic event on Holter by 48 hours was more common among patients with an abnormal post-PCI TMPG (12.5% vs 7.0%, P = .013), and the mean normalized duration of ischemia by 24 hours after PCI on Holter monitoring trended longer among patients with an abnormal post-PCI TMPG (8.9 vs 3.2 minutes, P = .068). "
06/01/2008 - "We compared initial and repeat assessments of five quantitative parameters [e.g., minimum lumen diameter (MLD), ejection fraction (EF), etc.] and six qualitative parameters [e.g., TIMI myocardial perfusion grade (TMPG) or thrombus grade (TTG), etc.], as performed by differing technicians and separated by a year or more. "
09/01/2006 - "We hypothesized that even in the presence of a patent epicardial artery, residual thrombus would be associated with worsened TIMI myocardial perfusion grades (TMPG), independent of epicardial flow. "
07/01/2015 - "We evaluated the coronary patency, TIMI flow and TIMI myocardial perfusion grade (TMPG) in 6 patients presenting with STEMI due to stent thrombosis treated by thrombolysis followed by immediate PCI. "
07/09/2002 - "TMPG 0/1 remained independently associated with cTnT elevation (odds ratio, 1.81; P=0.02), even after adjusting for epicardial TIMI flow grade, presence of thrombus, and prior myocardial infarction. "
09/01/2006 - "The association between thrombus and impaired TMPG remained even after further adjustment for CTFC or TIMI flow grade. "
06/01/2012 - "Secondary end-points were thrombolysis in myocardial infarction (TIMI) grade flow, TIMI myocardial perfusion grade (TMPG) flow, left ventricular ejection fraction (LVEF) within 2 weeks, and bleeding complication. "
01/01/2015 - "Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet therapy strategy in PCI increased TMPG III, decreased major adverse cardiac events, and did not increase the incidence of bleeding and thrombocytopenia."
01/01/2015 - "Based on combination of dual the anti-platelet agents and ticagrelor for diabetic patients with AMI receiving PCI, the combination of half-dose tirofiban can effectively improve TIMI flow and TMPG myocardial tissue perfusion, and reduce the incidence of major adverse cardiac events (MACE) and severe bleeding."
05/01/2010 - "Poor myocardial perfusion, as assessed by TMPG score, may be a simple tool for the identification of patients at greater risk of atherosclerosis progression, especially the development of new lesions."
01/01/2009 - "We analyzed the relationship between the severity of left ventricle diastolic dysfunction and atherosclerosis risk factors, infarction site, maximum levels of cardiac biomarkers such as troponin I, CPK and CK-MB, CRP protein levels, angioplasty effectiveness, reperfusion time, TIMI and TMPG grade. "
|1.||S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)
|7.||glucuronyl glucosamine glycan sulfate (Vessel)
|2.||Angioplasty (Angioplasty, Transluminal)